BRUSSELS — AstraZeneca cut its supply forecast of COVID-19 vaccine to the European Union in the first quarter to about 30 million doses, a third of its contractual obligations and a 25% drop from pledges made last month, a document seen by Reuters shows.
The shortfall is a further blow to EU’s vaccination plans already being hampered by repeated delays in supply and a slow rollout in some nations.
The AstraZeneca document, shared with EU officials and dated March 10, shows that the company now expects to deliver 30.1 million doses by the end of March, and another 20 million in April.
On Feb. 25, AstraZeneca boss Pascal Soriot told the European Parliament that the company w…
Keep on reading: AstraZeneca further cuts EU vaccine supply target to 30 million — document